What We're Reading: Page 89
Industry reads hand-picked by our editors
May 08, 2023
-
Reuters
After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic
-
Science
‘It’s still killing and it’s still changing.’ Ending COVID-19 states of emergency sparks debate
-
Healthcare Dive
CDC Director Walensky to step down in June
-
The New York Times
Liz Holmes Wants You to Forget About Elizabeth
May 05, 2023
May 04, 2023
May 03, 2023
-
Fierce Pharma
Neurocrine gives up on Parkinson’s drug Ongentys
-
Reuters
Haleon not surprised by Pfizer stake sale plans, says CFO
-
Evaluate Vantage
Mirasol knockout puts the pressure on Sutro
May 02, 2023
-
Bloomberg
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
-
The Wall Street Journal
In the Fight Against Aging, a Drug Called Rapamycin Captures Attention
-
Evaluate Vantage
The sellside hacks back Lynparza’s prostate opportunity
May 01, 2023
Apr 28, 2023
-
Science
Who is Monica Bertagnolli, Biden’s pick to lead NIH?
-
Politico
The real reason Europe’s medicines industry is dying
-
The Wall Street Journal
Congress Considers Paying Developers of New Antibiotics
-
MedTech Dive
Illumina gets cybersecurity warning from FDA over sequencing software
Previous
